Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder

Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and... Curr Sex Health Rep (2017) 9:192–199 https://doi.org/10.1007/s11930-017-0124-3 FEMALE SEXUAL DYSFUNCTION AND DISORDERS (M CHIVERS AND C PUKALL, SECTION EDITORS) Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder Stephanie Both Published online: 19 October 2017 The Author(s) 2017, corrected publication November/2017. This article is an open access publication Abstract Definition and Prevalence of Female Sexual Interest Purpose of Review This review summarizes the recent litera- and Arousal Disorder ture and empirical studies on psychopharmacological ap- proaches to treating female sexual interest/arousal disorder Female sexual interest/arousal disorder (FSIAD) is character- (FSIAD). ized by a lack of, or significantly reduced, sexual interest and/ Recent Findings Several new drugs for FSIAD that are or arousal [1]. It is manifested by at least three of the following intended to increase sexual responsiveness by influencing symptoms: (1) absent or reduced interest in sexual activity, (2) central excitatory and inhibitory neuromodulatory processes absent or reduced erotic thoughts or fantasies, (3) no or re- are under development. Studies on flibanserin resulted in the duced initiation of sexual activity and typical unreceptivity to first approved medication for the treatment of low sexual de- apartner’s attempts to initiate, (4) absent or reduced sexual sire http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Sexual Health Reports Springer Journals

Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder

Loading next page...
 
/lp/springer_journal/recent-developments-in-psychopharmaceutical-approaches-to-treating-cCpj3btrdW
Publisher
Springer US
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Urology; Endocrinology
ISSN
1548-3584
eISSN
1548-3592
D.O.I.
10.1007/s11930-017-0124-3
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial